Here are your comprehensive USMLE-focused Bacteriology Notes, synthesized from Jawetz, Melnick & Adelberg's Medical Microbiology 28e, Henry's Clinical Diagnosis & Management, and Sherris & Ryan's Medical Microbiology 8e:
🦠 BACTERIOLOGY - Detailed USMLE Notes
SECTION 1: FUNDAMENTALS OF BACTERIA
1.1 Prokaryote vs. Eukaryote - Key Differences
| Feature | Prokaryote (Bacteria) | Eukaryote (Human Cell) |
|---|
| Nuclear membrane | Absent | Present |
| Chromosome | Single circular, haploid | Multiple linear, diploid |
| Cell wall | Present (peptidoglycan) | Absent |
| Ribosomes | 70S (30S + 50S) | 80S (40S + 60S) |
| Size | ~1 µm | 10-100 µm |
| Mitochondria | Absent | Present |
| Introns | Rare (except Archaebacteria) | Common |
High-Yield: Antibiotics targeting 70S ribosomes (aminoglycosides, macrolides, tetracyclines, chloramphenicol, linezolid) selectively kill bacteria without harming human 80S ribosomes.
1.2 Bacterial Cell Wall
Gram-Positive vs. Gram-Negative
| Feature | Gram-Positive (+) | Gram-Negative (-) |
|---|
| Peptidoglycan layer | Thick (multilayer) | Thin (single layer) |
| Outer membrane | Absent | Present |
| LPS (endotoxin) | Absent | Present |
| Teichoic acid | Present | Absent |
| Periplasmic space | Narrow | Wide |
| Crystal violet stain | Purple | Red (decolorized) |
Gram Stain Steps (mnemonic: "Crystal Violet Girls Are Pretty"):
- Crystal Violet (primary stain) - all bacteria purple
- Gram Iodine (mordant) - fixes crystal violet
- Alcohol/Acetone (decolorizer) - washes out gram-negative
- Safranin (counterstain) - gram-negatives turn red/pink
Gram-positive exceptions (don't stain well):
- Mycobacteria - use Acid-Fast stain (Ziehl-Neelsen)
- Mycoplasma - NO cell wall at all
- Treponema - too thin, use dark-field microscopy
- Chlamydia/Rickettsia - obligate intracellular
1.3 Special Bacterial Structures
| Structure | Bacteria | Clinical Significance |
|---|
| Capsule | S. pneumoniae, H. influenzae, N. meningitidis, K. pneumoniae | Anti-phagocytic; polysaccharide = T-independent antigen |
| Endospore | Bacillus, Clostridium | Heat/chemical-resistant; autoclave at 121°C to kill |
| Flagella | E. coli, Salmonella, Vibrio | Motility; H antigen |
| Pili/Fimbriae | N. gonorrhoeae, E. coli | Adhesion, colonization |
| Biofilm | P. aeruginosa, S. epidermidis | Resistant to antibiotics; found on catheters |
Mnemonic for encapsulated bacteria: "Some Killers Have Pretty Nice Capsules"
- Streptococcus pneumoniae
- Klebsiella pneumoniae
- H. influenzae type b
- Pseudomonas aeruginosa
- Neisseria meningitidis
- Cryptococcus neoformans (fungus, but same concept)
SECTION 2: BACTERIAL CLASSIFICATION
2.1 Gram-Positive Cocci
| Organism | Key Features | Disease | Treatment |
|---|
| S. aureus | Coagulase+, catalase+, beta-hemolytic, golden colonies | Skin infections, osteomyelitis, endocarditis, toxic shock syndrome, food poisoning | Nafcillin (MSSA); Vancomycin (MRSA) |
| S. epidermidis | Coagulase-, novobiocin-sensitive | Prosthetic valve endocarditis, catheter infections | Vancomycin |
| S. saprophyticus | Coagulase-, novobiocin-resistant | UTI in young sexually active women | TMP-SMX |
| S. pneumoniae | Alpha-hemolytic, lancet-shaped diplococci, optochin-sensitive, bile-soluble | Pneumonia, meningitis, otitis media, sinusitis | Penicillin G (amoxicillin); ceftriaxone if resistant |
| S. pyogenes (GAS) | Beta-hemolytic, bacitracin-sensitive, PYR+ | Strep throat, rheumatic fever, scarlet fever, necrotizing fasciitis | Penicillin |
| S. agalactiae (GBS) | Beta-hemolytic, bacitracin-resistant, CAMP test+ | Neonatal meningitis/sepsis, postpartum endometritis | Ampicillin |
| Enterococcus | Grows in 6.5% NaCl, PYR+ | UTI, endocarditis, biliary infection | VRE: Linezolid/Daptomycin |
Viridans Streptococci (alpha-hemolytic, optochin-resistant):
- S. mutans - dental caries
- S. mitis/sanguis - subacute bacterial endocarditis (especially on damaged valves)
2.2 Gram-Negative Cocci
| Organism | Key Features | Disease | Treatment |
|---|
| N. gonorrhoeae | Oxidase+, ferments glucose only, no polysaccharide capsule, no normal flora | Gonorrhea, PID, neonatal ophthalmia, septic arthritis | Ceftriaxone + azithromycin |
| N. meningitidis | Oxidase+, ferments glucose AND maltose, has capsule | Meningococcal meningitis, Waterhouse-Friderichsen syndrome | Penicillin G; prophylaxis: rifampin/ciprofloxacin |
| Moraxella catarrhalis | Oxidase+, beta-lactamase producer | Otitis media, sinusitis, COPD exacerbations | Amoxicillin-clavulanate |
2.3 Gram-Positive Rods (Bacilli)
| Organism | Spore? | Key Features | Disease |
|---|
| B. anthracis | Yes | Non-motile, "Medusa head" colonies, anthrax toxin | Cutaneous anthrax (malignant pustule), inhalation anthrax (woolsorter's disease) |
| B. cereus | Yes | Motile | Food poisoning (reheated rice = preformed toxin; nausea 1-5h) |
| C. difficile | Yes | Pseudomembranous colitis, toxin A+B | Colitis post-antibiotics; treat with vancomycin PO or fidaxomicin |
| C. perfringens | Yes | Gas gangrene (lecithinase/alpha toxin), food poisoning (spores survive cooking) | Gas gangrene, food poisoning |
| C. tetani | Yes | Terminal spores (drumstick appearance), tetanospasmin (blocks GABA/glycine) | Tetanus (spastic paralysis, trismus) |
| C. botulinum | Yes | Preformed toxin, blocks ACh release at NMJ | Botulism (flaccid paralysis, descending) |
| Listeria monocytogenes | No | Tumbling motility, grows at 4°C (cold-enrichment), CAMP+, intracellular | Neonatal meningitis, septicemia in pregnancy, listeriosis in immunocompromised |
| Corynebacterium diphtheriae | No | Club-shaped, metachromatic granules, Loeffler/tellurite media | Diphtheria (pseudomembrane, myocarditis, neuropathy) |
| Actinomyces israelii | No | Anaerobic, branching, sulfur granules in pus | Cervicofacial actinomycosis ("lumpy jaw") |
| Nocardia | No | Aerobic, partially acid-fast, branching | Pulmonary infection in immunocompromised; brain abscess |
C. tetani vs. C. botulinum:
- Tetanus: ascending spastic paralysis, toxin travels retrograde via neurons
- Botulism: descending flaccid paralysis, blocks presynaptic ACh release
2.4 Gram-Negative Rods - Enterobacteriaceae
Family features: Oxidase-negative, ferment glucose, reduce nitrates, facultative anaerobes
| Organism | Key Tests | Disease | Treatment |
|---|
| E. coli | Indole+, MUG+, lactose fermenter | UTI (#1 cause), neonatal meningitis (K1 antigen), traveler's diarrhea (ETEC), EHEC O157:H7 (HUS), neonatal sepsis | Fluoroquinolones (UTI); ceftriaxone (meningitis) |
| Klebsiella pneumoniae | Urease+, lactose+, capsule | "Currant jelly" sputum pneumonia, UTI, nosocomial infections | Ceftriaxone; carbapenems for ESBL |
| Proteus mirabilis | Urease+, swarming motility, struvite stones | UTI, struvite (staghorn) kidney stones | Fluoroquinolones; TMP-SMX |
| Salmonella | H2S+, no lactose, motile | Typhoid fever (S. typhi), gastroenteritis (non-typhi), septicemia in sickle cell | Ciprofloxacin/ceftriaxone (typhi); supportive (non-typhi) |
| Shigella | No H2S, no lactose, non-motile, no gas | Dysentery (bloody diarrhea), HUS (S. dysenteriae), very low infective dose (10 organisms) | Ciprofloxacin or ceftriaxone (severe); self-limited otherwise |
| Yersinia enterocolitica | Oxidase-, cold-tolerant | Bloody diarrhea, pseudo-appendicitis (mesenteric lymphadenitis), reactive arthritis | Fluoroquinolones for severe cases |
| H. influenzae | Requires factors X (hemin) and V (NAD), "satellite phenomenon" | Epiglottitis (type b), meningitis (children), otitis media, sinusitis | Ceftriaxone; prophylaxis: rifampin |
Mnemonic for Lactose Fermenters (pink on MacConkey): "CEEK"
- Citrobacter
- Enterobacter
- E. coli
- Klebsiella
Non-Lactose Fermenters (colorless on MacConkey):
- Shigella, Salmonella, Proteus, Pseudomonas, Yersinia
2.5 Gram-Negative Rods - Non-Enterobacteriaceae
| Organism | Key Features | Disease | Treatment |
|---|
| Pseudomonas aeruginosa | Oxidase+, non-fermenter, blue-green pigment (pyocyanin), grape odor, aerobic | Burn/wound infections, pneumonia in CF patients, hot tub folliculitis, malignant otitis externa | Antipseudomonal beta-lactam + aminoglycoside |
| Haemophilus ducreyi | Requires factor X only | Chancroid (painful genital ulcer, painful inguinal lymphadenopathy) | Azithromycin or ceftriaxone |
| Bordetella pertussis | Bordet-Gengou agar, filamentous hemagglutinin + pertussis toxin | Whooping cough (catarrhal -> paroxysmal -> convalescent phase) | Azithromycin/erythromycin; vaccine (DTaP) |
| Legionella pneumophila | Silver stain, charcoal yeast extract agar with L-cysteine and iron, gram stain often negative clinically | Legionnaires' disease (severe atypical pneumonia), Pontiac fever | Azithromycin or fluoroquinolone |
| Helicobacter pylori | Urease+, oxidase+, catalase+, corkscrew motility | Peptic ulcer disease (>95% duodenal), gastric carcinoma, MALToma | Triple therapy: PPI + clarithromycin + amoxicillin |
| Brucella | Intracellular, undulant fever | Brucellosis (undulant fever, from unpasteurized dairy, animal contact) | Doxycycline + rifampin |
| Francisella tularensis | Tick or rabbit contact | Tularemia (ulceroglandular, pneumonic) | Streptomycin/gentamicin |
| Vibrio cholerae | Comma-shaped, oxidase+, rice-water diarrhea, cholera toxin (↑cAMP) | Cholera (profuse watery diarrhea, "rice-water stool") | Oral rehydration; doxycycline |
| Campylobacter jejuni | Oxidase+, grows at 42°C, comma/S-shaped | #1 cause of bacterial gastroenteritis in USA; bloody diarrhea; precedes Guillain-Barre syndrome | Azithromycin/fluoroquinolone |
2.6 Anaerobes
| Organism | Features | Disease | Treatment |
|---|
| Bacteroides fragilis | Capsule, polysaccharide, most common gut anaerobe | Intra-abdominal abscesses, peritonitis | Metronidazole; beta-lactam/beta-lactamase inhibitors |
| Fusobacterium | Spindle-shaped | Lemierre syndrome (septic jugular thrombophlebitis) | Metronidazole |
| Prevotella | Part of oral flora | Aspiration pneumonia, dental abscesses | Metronidazole + amoxicillin |
SECTION 3: ATYPICAL BACTERIA
3.1 Obligate Intracellular Bacteria
| Organism | Vector/Transmission | Disease | Test | Treatment |
|---|
| Rickettsia rickettsii | Tick | Rocky Mountain Spotted Fever (petechial rash: wrists/ankles -> trunk, fever, headache) | Weil-Felix reaction; immunofluorescence | Doxycycline |
| Rickettsia prowazekii | Body louse | Epidemic typhus | Weil-Felix | Doxycycline |
| Chlamydia trachomatis | STI/contact | Serovars A-C: trachoma (blindness); D-K: urethritis, PID, neonatal conjunctivitis; L1-L3: lymphogranuloma venereum | NAAT | Azithromycin (single dose) or doxycycline |
| C. pneumoniae | Respiratory droplets | Atypical pneumonia | Serology | Azithromycin |
| Coxiella burnetii | Aerosol from cattle/sheep | Q fever (no rash, no vector, spore-like forms in environment) | Serology | Doxycycline |
| Ehrlichia | Tick | Ehrlichiosis (fever, leukopenia, thrombocytopenia) | Morulae in monocytes | Doxycycline |
| Anaplasma | Tick (Ixodes) | Anaplasmosis (fever, leukopenia) | Morulae in granulocytes | Doxycycline |
3.2 Mycobacteria (Acid-Fast Organisms)
| Organism | Features | Disease | Treatment |
|---|
| M. tuberculosis | Cord factor (virulence), Ghon complex (primary), caseating granulomas | TB (pulmonary, miliary, meningitis, Pott disease of spine) | RIPE: Rifampin + Isoniazid + Pyrazinamide + Ethambutol |
| M. leprae | Cannot culture in vitro, grows in armadillos, grows at cooler temperatures | Leprosy: Tuberculoid (paucibacillary, cell-mediated) vs. Lepromatous (multibacillary, humoral) | Dapsone + rifampin (tuberculoid); add clofazimine (lepromatous) |
| M. avium complex (MAC) | Disseminated in AIDS (CD4 <50) | Fever, weight loss, night sweats, diarrhea | Clarithromycin + ethambutol |
| M. marinum | Aquatic (fish tanks/swimming pools) | Skin granulomas | Minocycline or clarithromycin |
| M. scrofulaceum | Cervical lymphadenopathy in children | Scrofula | Surgical excision |
TB Drug Side Effects (USMLE classic):
| Drug | Side Effect |
|---|
| Rifampin | Red/orange body fluids, hepatotoxicity, CYP inducer |
| Isoniazid | Peripheral neuropathy (B6 deficiency), hepatotoxicity, SLE-like |
| Pyrazinamide | Hyperuricemia (gout), hepatotoxicity |
| Ethambutol | Optic neuritis (red-green color blindness), retrobulbar neuritis |
3.3 Mycoplasma
| Organism | Features | Disease | Treatment |
|---|
| M. pneumoniae | No cell wall, smallest free-living bacterium, "walking pneumonia", cold agglutinins (IgM) | Atypical (walking) pneumonia - bilateral interstitial infiltrates, mild symptoms | Azithromycin or doxycycline (NOT beta-lactams) |
| M. hominis/U. urealyticum | Urease positive | Urethritis, PID | Doxycycline |
High-Yield: Mycoplasma lacks a cell wall - beta-lactams (penicillins, cephalosporins) are completely ineffective.
3.4 Spirochetes
| Organism | Disease | Key Features | Treatment |
|---|
| Treponema pallidum | Syphilis | Primary: painless chancre; Secondary: maculopapular rash (palms/soles), condylomata lata, fever; Tertiary: gummas, aortitis, tabes dorsalis; Congenital: saddle nose, Hutchinson teeth | Penicillin G (all stages) |
| Borrelia burgdorferi | Lyme disease | Stage 1: Erythema migrans (bull's-eye); Stage 2: Bell palsy, AV block, migratory arthritis; Stage 3: Chronic arthritis, encephalopathy | Doxycycline (early); ceftriaxone (late/neuro) |
| Leptospira interrogans | Leptospirosis | Animal urine (rats); biphasic: flu-like then Weil disease (jaundice, renal failure, hemorrhage) | Penicillin G or doxycycline |
Syphilis Serology:
- Non-treponemal tests (screening): VDRL, RPR - can have false positives (SLE, pregnancy, drug use)
- Treponemal tests (confirmatory): FTA-ABS, TPPA - specific
SECTION 4: BACTERIAL PATHOGENESIS & VIRULENCE
4.1 Toxins
Exotoxins vs. Endotoxin:
| Feature | Exotoxin | Endotoxin (LPS) |
|---|
| Source | Gram+ and Gram- bacteria, secreted | Gram- outer membrane, released on lysis |
| Chemistry | Protein | Lipopolysaccharide (lipid A is toxic) |
| Heat stability | Labile (except staph food poisoning) | Stable |
| Toxoid vaccine | Yes (tetanus, diphtheria) | No |
| Potency | Very high | Moderate |
| Fever production | Variable | Yes (strong pyrogenic via IL-1, IL-6, TNF) |
Key Exotoxin Mechanisms:
| Toxin | Organism | Mechanism |
|---|
| Cholera toxin | V. cholerae | ADP-ribosylates Gs → ↑cAMP → Cl-/water secretion |
| Pertussis toxin | B. pertussis | ADP-ribosylates Gi → ↑cAMP → impairs immune cell signaling |
| Diphtheria toxin | C. diphtheriae | ADP-ribosylates EF-2 → blocks protein synthesis |
| Anthrax toxin | B. anthracis | Edema factor (↑cAMP), Lethal factor (MAPK protease) |
| TSST-1 | S. aureus | Superantigen - non-specific MHC II binding → massive cytokine release |
| Exfoliative toxin | S. aureus | Serine protease, cleaves desmoglein-1 → SSSS |
| Shiga toxin | S. dysenteriae / EHEC | Inactivates 60S ribosome → cell death → HUS |
| Tetanus toxin | C. tetani | Blocks GABA/glycine release in spinal inhibitory interneurons → spastic paralysis |
| Botulinum toxin | C. botulinum | Cleaves SNARE proteins → blocks ACh vesicle release → flaccid paralysis |
Mnemonic - ADP-ribosylating toxins: "ABCDE"
- Anthrax (EF), Bordetella pertussis, Cholera, Diphtheria, E. coli (ETEC - LT toxin like cholera)
4.2 Virulence Factors
| Factor | Example | Function |
|---|
| Capsule | S. pneumoniae | Inhibits phagocytosis; T-independent antigen |
| Protein A | S. aureus | Binds Fc region of IgG → inhibits opsonization |
| IgA protease | S. pneumoniae, N. meningitidis, H. influenzae | Cleaves secretory IgA on mucous membranes |
| M protein | S. pyogenes | Anti-phagocytic, mimics host proteins → molecular mimicry → rheumatic fever |
| Coagulase | S. aureus | Fibrin clot formation → abscess formation |
| Leukocidin | S. aureus, P. aeruginosa | Kills WBCs |
| Collagenase | C. perfringens | Tissue destruction in gas gangrene |
| Adhesins/Pili | N. gonorrhoeae | Attachment to urogenital epithelium |
SECTION 5: ANTIBIOTIC MECHANISMS & RESISTANCE
5.1 Antibiotic Classification by Mechanism
| Mechanism | Antibiotics |
|---|
| Cell wall synthesis inhibition | Beta-lactams (penicillins, cephalosporins, carbapenems, monobactams), Vancomycin (glycopeptide - inhibits transpeptidation via D-Ala-D-Ala binding) |
| 30S ribosome inhibition | Aminoglycosides (bactericidal), Tetracyclines (bacteriostatic) |
| 50S ribosome inhibition | Chloramphenicol, Macrolides (azithromycin, erythromycin), Linezolid, Clindamycin |
| DNA gyrase / Topoisomerase II/IV | Fluoroquinolones |
| RNA polymerase | Rifampin |
| Cell membrane disruption | Polymyxins (B and E/colistin), Daptomycin (gram-positive only) |
| Folic acid synthesis | Sulfonamides (inhibit PABA utilization), TMP (inhibits dihydrofolate reductase) |
Mnemonic for 50S inhibitors: "Buy AT 50, CLean"
- B-nothing / Azithromycin / Tetracycline (actually 30S - keep for contrast) / Chloramphenicol / Linezolid / Clindamycin
5.2 Resistance Mechanisms
| Mechanism | Example |
|---|
| Beta-lactamase production | S. aureus (penicillinase), ESBL gram-negatives |
| Altered PBPs (penicillin-binding proteins) | MRSA (mecA gene - PBP2a has low affinity for beta-lactams) |
| Efflux pumps | P. aeruginosa, tetracycline resistance |
| Modified ribosomal target | Vancomycin-resistant Enterococcus (VRE) - D-Ala-D-Ala changed to D-Ala-D-Lac |
| Enzymatic inactivation | Aminoglycoside-modifying enzymes (acetylation, phosphorylation) |
| Reduced permeability | P. aeruginosa (porin changes) |
SECTION 6: HIGH-YIELD CLINICAL ASSOCIATIONS
6.1 Disease-Bug Associations (High Yield)
| Clinical Scenario | Organism |
|---|
| UTI in young woman | E. coli |
| UTI in young sexually active woman (recurrent) | S. saprophyticus |
| Neonatal meningitis | E. coli (K1), S. agalactiae (GBS), Listeria |
| Meningitis in adults | S. pneumoniae, N. meningitidis |
| Meningitis in elderly/immunocompromised | Listeria monocytogenes |
| Septic arthritis in young adults | N. gonorrhoeae |
| Septic arthritis in children | S. aureus |
| Pneumonia in alcoholic | K. pneumoniae, S. pneumoniae |
| Pneumonia in cystic fibrosis | P. aeruginosa, S. aureus, Burkholderia cepacia |
| Pneumonia with diarrhea + hyponatremia | Legionella pneumophila |
| "Walking pneumonia" in young adult | Mycoplasma pneumoniae |
| Traveler's diarrhea | ETEC (E. coli) |
| Bloody diarrhea after hamburger | EHEC O157:H7 |
| Bloody diarrhea, pseudo-appendicitis | Yersinia enterocolitica |
| Ascending cholangitis (Charcot's triad) | E. coli, Enterococcus, Klebsiella |
| Endocarditis - IV drug user | S. aureus (tricuspid valve) |
| Endocarditis - dental procedure | Viridans streptococci |
| Wound infection after surgery/trauma | C. perfringens (gas gangrene), S. aureus |
| Bite wound infection (human) | Eikenella corrodens |
| Bite wound infection (dog/cat) | Pasteurella multocida |
| Cat scratch disease | Bartonella henselae |
6.2 Special Culture Media
| Media | Organism Isolated |
|---|
| Blood agar | General purpose; see hemolysis patterns |
| MacConkey | Gram-negatives; differentiates lactose fermenters |
| Chocolate agar | H. influenzae, N. gonorrhoeae |
| Thayer-Martin (VCN) | Neisseria species |
| Charcoal-yeast extract + L-cysteine/iron | Legionella |
| Bordet-Gengou | Bordetella pertussis |
| Löffler's / Tellurite | C. diphtheriae |
| Lowenstein-Jensen | Mycobacterium tuberculosis |
| TCBS (thiosulfate-citrate-bile salt-sucrose) | Vibrio cholerae |
| Buffered charcoal yeast extract (BCYE) | Legionella |
| Regan-Lowe | B. pertussis |
6.3 Special Stains
| Stain | Organisms |
|---|
| Gram stain | Most bacteria |
| Ziehl-Neelsen (acid-fast) | Mycobacteria, Nocardia (partially) |
| India ink | Cryptococcus neoformans (fungus, but commonly tested with bacteria) |
| Silver stain (Warthin-Starry) | Legionella, H. pylori, Treponema |
| PAS (Periodic Acid-Schiff) | Tropheryma whipplei (Whipple disease) |
| Giemsa | Rickettsia, Borrelia, Plasmodium, Trypanosoma |
| Dark-field microscopy | Treponema pallidum |
6.4 Toxin-Mediated Diseases - Quick Table
| Disease | Toxin | Key Feature |
|---|
| Toxic shock syndrome (TSS) | TSST-1 (S. aureus) or Strep pyrogenic exotoxin | Superantigen, multiorgan failure, hypotension |
| Scalded skin syndrome (SSSS) | Exfoliative toxin (S. aureus) | Nikolsky sign+, superficial blisters |
| Diphtheria | Diphtheria toxin (encoded by beta-phage) | Pseudomembrane, myocarditis, neuropathy |
| Botulism | Botulinum toxin (serotypes A,B,E most common) | Descending flaccid paralysis, diplopia, dysphagia |
| Tetanus | Tetanospasmin | Ascending spastic paralysis, lockjaw |
| HUS | Shiga toxin | EHEC O157:H7 or S. dysenteriae; triad: microangiopathic hemolytic anemia + thrombocytopenia + renal failure |
| Cholera | Cholera toxin (↑cAMP) | Rice-water diarrhea, no fever, no WBCs in stool |
SECTION 7: GENETICS & RESISTANCE TRANSFER
7.1 Methods of Genetic Transfer
| Method | Description | Example |
|---|
| Transformation | Uptake of naked DNA from environment | S. pneumoniae (Griffith's experiment) |
| Transduction | DNA transferred via bacteriophage | S. aureus exotoxins (TSST-1, exfoliative), C. botulinum toxin, C. diphtheriae toxin |
| Conjugation | Direct cell-to-cell plasmid transfer via pilus (F pilus) | Gram-negative bacteria; spread of antibiotic resistance plasmids |
| Transposition | Movement of DNA segments (transposons) within/between genomes | Resistance genes jumping between plasmids |
Toxins encoded by phages (bacteriophages) - mnemonic: "ABCDE Toxins"
- Anthrax (no, this is chromosome/plasmid)
- Botulinum toxin
- Cholera toxin
- Diphtheria toxin
- Erythrogenic toxin of S. pyogenes (Scarlet fever)
- Also: Shiga-like toxin of EHEC
SECTION 8: NORMAL FLORA & DISRUPTION
| Site | Dominant Organisms |
|---|
| Skin | S. epidermidis, Propionibacterium acnes, Corynebacteria |
| Oropharynx | Viridans streptococci, Neisseria, H. influenzae |
| Colon | Bacteroides fragilis (most common), E. coli, Enterococcus |
| Vagina | Lactobacillus (produces lactic acid, maintains low pH) |
| Urethra | S. epidermidis, corynebacteria |
Clinical Relevance:
- Disruption of colonic flora (antibiotics) → C. difficile overgrowth → pseudomembranous colitis
- Disruption of vaginal flora (antibiotics/pH change) → Candida overgrowth or bacterial vaginosis (Gardnerella)
QUICK REVIEW MNEMONICS
Bugs that do NOT gram stain well (need special stains):
"These Rascals May Micro-Copulate Lovingly"
- Treponema (dark-field)
- Rickettsia (Giemsa)
- Mycobacteria (Ziehl-Neelsen)
- Mycoplasma (no cell wall)
- Chlamydia (intracellular)
- Legionella (silver stain)
Bugs transmitted by ticks:
"Rocky Bouncin' Lyme ERA"
- Rickettsia rickettsii (RMSF)
- Borrelia burgdorferi (Lyme)
- Lyme (Borrelia)
- Ehrlichia
- Anaplasma
Antibiotics to AVOID in pregnancy:
"SAFE Moms Take Really Good Care" (drugs that are SAFE vs. AVOID)
AVOID: Tetracyclines (teeth/bones), Fluoroquinolones (cartilage), Sulfonamides (neonatal jaundice, G3P trimester), Metronidazole (1st trimester), Aminoglycosides (fetal ototoxicity), Chloramphenicol (gray baby syndrome)
Sources: Jawetz, Melnick & Adelberg's Medical Microbiology 28e; Henry's Clinical Diagnosis & Management by Laboratory Methods; Sherris & Ryan's Medical Microbiology 8eThese are your complete Bacteriology Notes for USMLE preparation. Here's what's covered:
What's in these notes:
- Fundamentals - Prokaryote structure, cell wall, Gram stain technique and interpretation
- Gram-Positive Cocci - Staph, Strep, Enterococcus with key differentiating tests
- Gram-Positive Rods - Spore-formers (Bacillus/Clostridium), non-spore-formers (Listeria, Diphtheria, Nocardia, Actinomyces)
- Gram-Negative Rods - Enterobacteriaceae (E. coli, Salmonella, Shigella, Klebsiella) + non-Enterobacteriaceae (Pseudomonas, Legionella, H. pylori, Vibrio, Campylobacter)
- Atypical Bacteria - Obligate intracellulars (Rickettsia, Chlamydia, Coxiella), Mycobacteria (TB, leprosy, MAC), Mycoplasma, Spirochetes (Syphilis, Lyme, Leptospira)
- Pathogenesis - Exotoxins vs. endotoxin, virulence factors, toxin mechanisms
- Antibiotics - Mechanism of action by class, resistance mechanisms
- Clinical Correlations - High-yield bug-disease associations, special media, special stains
- Genetics - Transformation, transduction, conjugation, phage-encoded toxins
- Mnemonics throughout for fast retention
Let me know if you want me to go deeper on any specific section (e.g., TB treatment details, antibiotic resistance, Salmonella/Shigella comparison, or a specific organism for viva/exam prep).